Skip to content

Silicon Laboratories SLAB Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months)

Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months) at other companies

Assurant logo
AssurantAIZ

Other financials

Income statement

See full
Revenue$213.5M+20.1%
Gross profit$127.0M+29.9%
Operating income-$17.1M+46.8%
Net income-$15.9M+47.8%
EPS (diluted)-$0.48+48.9%

Balance sheet

See full
Cash & equivalents$383.1M+17.9%
Total debt$24.0M+11.8%
Total equity$1.1B+2.8%
Total assets$1.3B+3.0%

Cash flow

See full
Operating cash flow$4.9M-89.7%
CapEx$9.8M+103%
Free cash flow-$4.9M-111%

Valuation

See full
Market cap$7.25B+113%
P/S8.8×+3.6×

Profitability

See full
Gross margin59.3%+5.1pp
Operating margin-6.8%-2.7pp
Net margin-6.1%-2.6pp
FCF margin-6.3%-21.8pp

Returns & leverage

See full
Return on equity-4.6%-1.9pp
Debt / equity0.0×
Current ratio5.1×-0.1×

Where this comes from

Reported directly by Silicon Laboratories in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months.

The official record: Silicon Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Silicon Laboratories's available-for-sale debt securities - unrealized loss position (<12 months).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Silicon Laboratories's available-for-sale debt securities - unrealized loss position (<12 months)?
Silicon Laboratories (SLAB) reported available-for-sale debt securities - unrealized loss position (<12 months) of $5.21M in Q1 2026.
How has Silicon Laboratories's available-for-sale debt securities - unrealized loss position (<12 months) changed year-over-year?
Silicon Laboratories's available-for-sale debt securities - unrealized loss position (<12 months) decreased by 36.7% year-over-year, from $8.24M to $5.21M.